Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research - Greece
doi 10.21873/anticanres.14109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Anticancer Research USA Inc.